Market Research Report
Global Dental Biomaterials Market - 2019-2026
|Published by||DataM Intelligence||Product code||845180|
|Published||Content info||130-180 Pages
Delivery time: 1-2 business days
|Global Dental Biomaterials Market - 2019-2026|
|Published: May 1, 2019||Content info: 130-180 Pages||
Dental biomaterials are specialized natural or synthetic products designed to be used in the preventive and restorative dentistry. These products are used to restore the damaged, decayed, or fractured teeth. Dental biomaterials are efficient products with a high success rate in oral treatment and prevention. These products replace the damaged or missing tooth tissues and also promote tissue regeneration. Natural biomaterials include enamel, dentin, cementum, bone, and other intraoral tissues and synthetic materials include metals, ceramics, polymers, and composite structures.
According to the World Health Organization (WHO), dental disorders are one of the major public health issues in most of the developed and developing countries. Most of the oral diseases are considered as noncommunicable diseases. The most common oral diseases include untreated caries in permanent teeth, untreated caries in deciduous teeth, and severe periodontitis in adults. The global age-standardized prevalence rates of these oral diseases in 2015 were 34.1%, 7.8%, and 7.4%, respectively
In developed countries, dental disorders affect 60% to 90% of children and 5% to 20% of middle-aged adults. Dental biomaterials are the primary choice of dentists in restructuring and preventing the teeth and gum damage.
The global dental biomaterials market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of XX% during the forecast period.
The market is driven by the growing prevalence of dental disorders, rising geriatric population, increasing demand for cosmetic dentistry, increase in expenditure on dental and oral care and increasing adoption of novel adhesives, resin cement in CAD/CAM and other digital technologies. Dental CAD/CAM technology includes the use of new materials and data acquisition. It is a non-destructive method of saving impressions, restorations, and information in a computer and acts as a communication tool for evaluation.
According to a systematic analysis study on the global burden of diseases, injuries, and risk factors, the number of people with untreated oral conditions worldwide increased from 2.5 million in 1990 to 3.5 billion in 2015, with a 64% increase in disability-adjusted life years (DALYs) due to oral conditions.
The rise in disposable income and dentists especially in developing countries is another key factor for the market growth. For instance, according to the Brazilian Institute of Geography and Statistics (IBGE), in 2019, Brazil has 174,000 dentists, which corresponds to 11% of the world's total population. Implementation of favorable policies and initiatives are also on rise in most of the developing countries. In 2014, Brazilian government has implemented the Oral Health National Policy. Awareness of oral health has notably increased post the implementation of the plan and the expenditure on dental care has increased substantially in the country.
In US dental expenditure is increasing because of awareness, rise in disposable income and inclination towards cosmetic dentistry.
High cost of treatment, presence of stringent regulatory and clinical processes and low reimbursement coverage by insurance are going to restrain the market in the forecast period. According to the WHO, every year oral diseases are among the most expensive diseases to be treated in developing as well as developed countries. According to the Organization for Economic Co-operation and Development (OECD), in 2013, the treatment of oral diseases including dental biomaterials was responsible for 5% of the overall health expenditure in developed countries.
In developing nations large chunk of dental care is spent out of pocket, for instance in China current basic medical insurance only covers a small portion of dental care expenditures, and over 85% of total dental costs are paid out of pocket.
In developed countries too, dental expenditures are not predominantly covered by the government. For instance, in the US dental expenditure is minimally covered by CMS or other private organizations, but majority of it is paid out of pocket. In 2017, Medicaid coverage for dental services accounted for $12.5 billion where as out-of-pocket expenditure accounted for 53.0 billion.
The global dental biomaterials market can be segmented by product as bone graft materials, dental membranes, and soft tissue regeneration products, by type as metallic, ceramic, and natural dental biomaterials, by application as implantology, periodontology, prosthodontics, orthodontics, and others and by end user as dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes.
By type, polymeric biomaterials are expected to dominate the market during the period of forecast because of high product durability, reduced risks of infections compared to other materials, material flexibility that provides ease in shape formation, biocompatibility, good resilience, lightweight, easy fabrication, and high corrosion resistance. Moreover, polymeric biomaterials have unique antimicrobial and drug delivery properties in preventive, regenerative, and restorative therapies to reduce friction and corrosion in dentistry.
By application, implantology is the highest growing segment in the dental biomaterials market due to increasing demand for dental implants as it transmits mechanical forces and stimulation into the jawbone and provides patients with natural activities of teeth. According to the American Academy of Implant Dentistry, in 2018, around 150 million people in the US were missing at least one tooth and around five million underwent dental restoration and it is growing annually by 500,000.
Geographically, the global dental biomaterials market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa.
North America is anticipated to account for a significant share of the global market over the period of forecast, owing to an increase in the geriatric population in the country. According to the American College of Prosthodontists (ACP), in 2018, around 23 million people in the US were completely edentulous and another 12 million are edentulous in one arch.
The market in the Asia Pacific is likely to expand at a significant CAGR during the forecast period. Increase in the geriatric population with missing teeth and rise in demand for aesthetics leading to higher adoption of dental implants are projected to boost the dental biomaterials market in the region. According to the Indian Dental Association (IDA), in 2018, about 30% of adults aged 65 years and older in India are edentulous, compared to 46% of the population 20 years ago, this is owing to higher adoption of dental biomaterial implants. The prevalence in China is significantly high. According to 4th national oral health epidemiology survey the percent of periodontally healthy people in middle-aged and elderly population category is just 12.6%.
Favorable government initiatives in APAC countries will have a positive impact on the APAC dental biomaterials market. The Central Committee of the Communist Party of China and the State Council of China released the Healthy China 2030 blueprint in October 2016. It includes policies for healthy lifestyles, optimization of health industries and improvement of health services including dental care. Recently, the Chinese Academy of Engineering (CAE) launched a strategic analysis project, 'The oral health management of China in 2035'. The initiative aims to analyze international trends in oral health promotion and identify the advantages and disadvantages of current oral health management measures in China and to identify frontiers for the competitive development of oral health in China.
Some of the major key players in the market are Straumann AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Kuraray Co., Ltd, Medtronic Plc., Henry Schein, Inc., Mitsui Chemicals ,Inc., Victrex Plc, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd, BEGO Medical GmbH, Cam Bioceramics B.V., Geistlich Pharma AG, BioHorizons IPH, Inc., and Biomatlante. Few of the recent key developments of the major players are list below -